Related Experiment Video
Updated: Mar 10, 2026

10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.6K
Research Review on Inhibitors of Lumpy Skin Disease Virus: From Biological Characteristics, Drug Repurposing, to
Leilei Zhao1, Jing Qu1, Miao An1
1Institute of Feed Research, Chinese Academy of Agricultural Sciences, Beijing, China, caas.cn.
International Journal of Microbiology
|March 9, 2026
Summary
Researchers reviewed lumpy skin disease virus (LSDV) inhibitors, detailing viral characteristics and replication proteins. This summary aids in developing new antiviral agents against LSDV using computer-aided drug design.
Area of Science:
- Veterinary Virology
- Antiviral Drug Discovery
- Computational Biology
Background:
- Lumpy skin disease virus (LSDV) poses a significant threat to livestock globally.
- Understanding LSDV replication mechanisms is crucial for developing effective treatments.
- Existing research on poxvirus inhibitors provides a foundation for LSDV-targeted therapies.
Purpose of the Study:
- To review current research on inhibitors targeting LSDV.
- To summarize the biological characteristics and key viral proteins of LSDV.
- To explore the potential of computer-aided drug design (CADD) in discovering novel LSDV inhibitors.
Main Methods:
- Literature review of direct-acting and host-directed poxvirus inhibitors.
- Analysis of inhibitor mechanisms of action and potential viral targets.
- Discussion of CADD methodologies, including virtual screening, for anti-LSDV research.
Main Results:
- Compilation of various poxvirus inhibitors and their modes of action.
- Identification of key LSDV proteins involved in viral replication.
- Exploration of CADD approaches for accelerating the discovery of anti-LSDV agents.
Conclusions:
- There is a need for targeted LSDV inhibitors based on known poxvirus strategies.
- CADD offers a promising avenue for identifying novel antiviral compounds against LSDV.
- Further research integrating computational and experimental methods can expedite the development of LSDV therapeutics.
Related Concept Videos
Drug Discovery: Overview
12.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.5K
Targets for Drug Action: Overview
10.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.9K
Retrovirus Life Cycles
50.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.2K

